Persistent Foramen Ovale Associated with Systemic Lupus as a Cause of Acute Ischemic Stroke - A Case Report

Mileusnic, Valentina; Zecevic, Aleksandra; Culafic, Slobodan; Matic, Tatjana Boskovic

doi:10.2478/sjecr-2022-0015

Abstract

Acute ischemic stroke (AIS) caused by occlusion of a large blood vessel in the neck and / or head presents a common clinical picture in patients with congenital heart defects with the combined existence of systemic diseases. This paper presents a 32 - year - old patient with AIS in the field of cardioembolization. Since it was an occlusion of a large blood vessel (supraclinoid part of the left ICA), an endovascular procedure of mechanical thrombus extraction was applied. Further examination revealed the presence of persistent foramen ovale (PFO) and systemic lupus (SLE) in this patient. The patient underwent percutaneous closure of ASD 5 months after EVT.

References

1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. doi:10.1161/CIR.0000000000000 485. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
2. O’Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention. Circulation. 2009;119:2743–2747.doi:10.1161/CIRCULATIONAH A.109.192272. [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
3. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493–501. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
4. Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg. 2010;110:135–147. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
5. Farb A, Ibrahim NG, Zuckerman BD. Patent foramen ovale after cryptogenic stroke—assessing the evidence for closure. N Engl J Med. 2017;377:1006–1009. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
6. Windecker S, Stortecky S, Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014;64:403–415. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
7. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
8. Ropper AH. Tipping point for patent foramen ovale closure. N Engl J Med. 2017;377:1093–1095. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
9. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Mayo Clin Proc. 1999;74:862–869. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
10. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112:141–145. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
11. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164:950–956. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
12. Kent DM, Thaler DE. The Risk of Paradoxical Embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. 2011;12:185. [PMC free article] [PubMed] [Google Scholar]
Search in Google Scholar Back to article
13. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81:619–625. [PMC free article] [PubMed] [Google Scholar]
Search in Google Scholar Back to article
14. Prefasi D, Martínez-Sánchez P, Fuentes B, Díez-Tejedor E. The utility of the RoPE score in cryptogenic stroke patients ⩽50 years in predicting a stroke-related patent foramen ovale. Int J Stroke. 2016;11:NP7–NP8. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
15. Shah MD. A look at atrial septal aneurysm. E-J ESC Council for Cardio Pract. 2012;10 https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-10/A-look-at-Atrial-Septal-Aneurysm. [Google Scholar]
Search in Google Scholar Back to article
16. Ding C, Chang JK, Lin CC, Wu YJ, Hsieh KS. Efficacy and safety of transthoracic echocardiography alone in transcatheter closure of secundum-type atrial septal defects in adults. Echocardiography. 2016;33:579–585. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
17. Pinto FJ. When and how to diagnose patent foramen ovale. Heart. 2005;91:438–440. doi:10.1136/hrt.2004. 052233. [PMC free article] [PubMed] [Cross-Ref] [Google Scholar]
Search in Google Scholar Back to article
18. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale. Circulation. 2002;105:2625–2631. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
19. Sacco RL, Prabhakaran S, Thompson JL, et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006;22:4–12. [PubMed] [Google Scholar]
Search in Google Scholar Back to article
20. Fanouriakis A, Boumpas DT, Bertsias GK. Pathogenesis and treatment of CNS lupus. Curr Opin Rheumatol 2013;25:577–83. [10.1097/BOR.0b013e328363eaf1] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
21. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011;41:1–11. [10.1016/j.semarthrit. 2010.08.001] [PMID: ] [PubMed] [Cross-Ref] [Google Scholar]
Search in Google Scholar Back to article
22. Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2018;70:1478–87. [10.1002/acr.23509] [PMID: ] [PMCID: ] [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
23. Saadatnia M, Sayed-Bonakdar Z, Mohammad-Sharifi G, Sarrami AH. The necessity of stroke prevention in patients with systemic lupus erythematosus. J Res Med Sci 2012;17: 894–5. [PMID: ] [PMCID: ] [PMC free article] [PubMed] [Google Scholar]
Search in Google Scholar Back to article
24. Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 2017;76:10–20. [10.1016/j.jaut.2016.10.004] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
25. Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 2013;43:77–95. [10.1016/j.semarthrit.2012.12.0 02] [PMID:] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article
26. Mok CC, Ho LY, To CH. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol 2009;38:362–8. [10.1080/03009740902776 927] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
Search in Google Scholar Back to article

Persistent Foramen Ovale Associated with Systemic Lupus as a Cause of Acute Ischemic Stroke - A Case Report

Abstract

Paradigm

My account